Stomach cancer surgery combo trial halted early
NCT ID NCT03042169
First seen Jan 03, 2026 · Last updated May 15, 2026 · Updated 21 times
Summary
This study looked at whether removing the main stomach tumor and the single spot it spread to, plus chemotherapy, helps people live longer than chemotherapy alone. It was for people with stage IV stomach cancer that had only spread to one other place. The trial was stopped early after enrolling only 6 people, so we cannot draw firm conclusions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ico - Site Gauducheau - St Herblain
Saint-Herblain, France
Conditions
Explore the condition pages connected to this study.